Dr. Megan Do
What this data tells you about Dr. Do
Dr. Megan Do is a cardiovascular disease in Texarkana, TX, with 15 years in practice. Based on federal Medicare data, Dr. Do performed 3,203 Medicare services across 2,011 unique beneficiaries.
Between the years covered by Open Payments, Dr. Do received a total of $3,235 from 22 pharmaceutical and/or device companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Do is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 529 | $6 | $9 |
| Office visit, established patient (30-39 min) | 429 | $78 | $127 |
| Echocardiogram, transthoracic | 325 | $82 | $120 |
| Regadenoson injection (Lexiscan) for heart stress test | 300 | $43 | $59 |
| Office visit, established patient (20-29 min) | 265 | $61 | $88 |
| Remote pacemaker/defibrillator monitoring, 90 days | 155 | $15 | $21 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 138 | $27 | $36 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 121 | $18 | $25 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 110 | $115 | $152 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 109 | $324 | $424 |
| Hospital follow-up visit, moderate complexity | 107 | $60 | $78 |
| Remote pacemaker monitoring, 90 days | 81 | $20 | $29 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 74 | $25 | $36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 57 | $16 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 57 | $10 | $23 |
| Electrocardiogram (EKG), 12-lead | 51 | $10 | $17 |
| Initial hospital admission, high complexity | 49 | $133 | $169 |
| New patient office visit (45-59 min) | 41 | $111 | $171 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $2 | $3 |
| Ultrasound of heart, follow-up | 26 | $19 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $9 | $15 |
| Hospital follow-up visit, high complexity | 25 | $91 | $118 |
| Cardiac catheterization | 21 | $199 | $312 |
| Heart muscle strain imaging | 20 | $28 | $36 |
| Programming of dual lead pacemaker system | 18 | $23 | $36 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 17 | $5 | $7 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $81 | $104 |
| Initial hospital admission, moderate complexity | 13 | $100 | $127 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Do is a cardiac & remote specialist, with moderate Medicare volume, and low-engagement industry engagement, with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Do experienced with ekg interpretation and report?
Does Dr. Do receive payments from pharmaceutical companies?
How do Dr. Do's costs compare to other cardiovascular diseases in Texarkana?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology